Johannes Rolin, Rønnaug Astri Ødegård, Viktoria Vedeler Amundsen, Unni Mette Stamnes Köpp, Ane Kokkvoll, Pétur Benedikt Júlíusson, Jøran Hjelmesæth
{"title":"Supplementary drug treatment to reduce weight in adolescents with severe obesity.","authors":"Johannes Rolin, Rønnaug Astri Ødegård, Viktoria Vedeler Amundsen, Unni Mette Stamnes Köpp, Ane Kokkvoll, Pétur Benedikt Júlíusson, Jøran Hjelmesæth","doi":"10.4045/tidsskr.22.0540","DOIUrl":null,"url":null,"abstract":"In 2021, the Norwegian Medicines Agency approved the use of daily injection of liraglutide 3.0 mg (Saxenda) as a supplement to lifestyle treatment for weight control in children ≥ 12 years of age with obesity (isoBMI ≥ 30). We share the treatment experiences of six multidisciplinary obesity clinics in the specialist health service.","PeriodicalId":520817,"journal":{"name":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4045/tidsskr.22.0540","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/11 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
In 2021, the Norwegian Medicines Agency approved the use of daily injection of liraglutide 3.0 mg (Saxenda) as a supplement to lifestyle treatment for weight control in children ≥ 12 years of age with obesity (isoBMI ≥ 30). We share the treatment experiences of six multidisciplinary obesity clinics in the specialist health service.